Integrated Filing — IndAS



General information about company

Scrip Code 543593
NSE Symbol DBOL
MSEI Symbol NOTLISTED
ISIN INE0I3401014
Name of company Dhampur Bio Organics Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 14-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 11-11-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 14-11-2026   11:35:00
End date and time of board meeting 14-11-2026   12:45:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 21-01-2026
Indicate Company website link for updated RPT policy of the Company www.dhampur.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
The Company has not defaulted on any loans and Debt securities.



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 99,315.00 1,93,270.00
Other income 247.00 342.00
Total income 99,562.00 1,93,612.00
2 Expenses
(a) Cost of materials consumed 5,612.00 12,161.00
(b) Purchases of stock-in-trade 5,977.00 14,839.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 38,768.00 68,462.00
(d) Employee benefit expense 2,977.00 5,327.00
(e) Finance costs 787.00 2,343.00
(f) Depreciation, depletion and amortisation expense 1,295.00 2,582.00
(f) Other Expenses
1 Excise duty on sale of goods 33,010.00 71,577.00
2 Other expenses 7,214.00 14,014.00
Total other expenses 40,224.00 85,591.00
Total expenses 95,640.00 1,91,305.00
3 Total profit before exceptional items and tax 3,922.00 2,307.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 3,922.00 2,307.00
6 Tax expense
7 Current tax 592.00 592.00
8 Deferred tax 668.00 267.00
9 Total tax expenses 1,260.00 859.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 2,662.00 1,448.00
12 Profit (loss) from discontinued operations before tax 0.00 6,218.00
13 Tax expense of discontinued operations 0.00 1,164.00
14 Net profit (loss) from discontinued operation after tax 0.00 5,054.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 2,662.00 6,502.00
17 Other comprehensive income net of taxes (337.00) (337.00)
18 Total Comprehensive Income for the period 2,325.00 6,165.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 6,639.00 6,639.00
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 4.05 2.21
Diluted earnings (loss) per share from continuing operations 4.03 2.2
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 7.68
Diluted earnings (loss) per share from discontinued operations 0 7.64
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 4.05 9.89
Diluted earnings (loss) per share from continuing and discontinued operations 4.03 9.84
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes to Standalone Financial Results i) These audited standalone financial results which are published in accordance with Regulation 33 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('Listing Regulations’) have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on November 14, 2026. These audited standalone financial results have been prepared in accordance with recognition and measurement principles of Indian Accounting Standards (Ind-AS) prescribed under Section 133 of the Companies Act, 2013, read with the relevant rules issued thereunder and the other accounting principles generally accepted in India. ii) The statutory auditors have expressed an unmodified opinion in the audit report for the quarter and six months ended September 30, 2026. iii) The figures for the quarter ended September 30, 2026 are the balancing figures between the audited figures in respect of the six months ended September 30, 2026 and the published unaudited year to date figures up to the first quarter of the current financial year. iv) The Company has three wholly owned subsidiaries Sonitron Bio Organics Private Limited, Dhampur International Pte. Limited and DBOL International Food & Beverages Trading FZE and one subsidiary DBION Private Limited (w.e.f. July 9, 2026) as on September 30, 2026. v) The Company granted 3,57,881 stock options to the eligible employees of the Company, which are convertibles into equal number of equity shares of the Company of face value of Rs. 10/- each, at exercise price of Rs. 40/- each, through Trust route under the DBO Employee Stock Option Scheme 2025 in the previous year. During the previous quarter ended June 30, 2026, 6600 stock options are forfeited due to separation of an employee before vesting of options. The Company granted interest free loan to the DBO Employee Welfare Trust (Trust) for acquisition of shares through open market. The outstanding amount of loan as at September 30, 2026 is Rs. 7.15 Crores (including Rs. 0.50 Crore and Rs. 1.65 Crore granted during the quarter and six months ended September 30, 2026 respectively). The Trust has acquired 7,74,383 shares (including 97,000 shares and 1,75,383 shares during the quarter and six months ended September 30, 2026 respectively) from the market at an average price of Rs. 91.77 per share. Acquisition cost of shares held by the Trust is presented as reduction in ‘Other Equity’. Share based payment expense for the quarter and six months ended September 30, 2026 is Rs. 0.11 Crore and Rs. 0.21 Crore respectively (Rs. 0.07 Crore for quarter and six months ended September 30, 2025; Rs. 0.10 Crore for the quarter ended June 30, 2026 & Rs. 0.28 Crore for the year ended March 31, 2026). During the quarter ended September 30, 2026, one eligible employee has exercised option to acquire 13,541 shares at the exercised price. The Company considers the Trust as an extension of the entity and accordingly, incorporated the financials of the Trust in the standalone financial statements of the Company. vi) During the previous quarter ended June 30, 2026, the Company sold one of its sugar manufacturing undertaking comprising sugar and co-generation plant located at Meerganj, Bareilly, Uttar Pradesh, (“Meerganj Unit”) on slump sale basis for an aggregate consideration of Rs. 305.00 Crores which has been approved by the shareholders in the EGM held on May 18, 2026. The said Meerganj unit is transferred with effect from June 18, 2026 and full consideration has been received by the Company resulting in the gain of Rs. 63.89 Crores on sale of the undertaking. The operations of the said Meerganj unit of the Company has been classified as the Discontinued Operations for all the periods presented in these standalone financial results of the Company, in accordance with the applicable accounting standards. The results of the business classified as discontinued operations in these standalone financial results are as under: Particulars Quarter Ended Six months ended Year ended 30-Sep-26 30-Jun-26 30-Sep-25 30-Sep-26 30-Sep-25 31-Mar-26 (Audited)* (Unaudited) (Unaudited) (Audited) (Unaudited) (Audited) (a) Revenue from operations and other income - 78.50 3.97 78.50 83.07 460.12 (b) Total expenses - 80.21 14.67 80.21 105.85 470.27 (c) Profit/ (Loss) before tax ((a)-(b)) - (1.71) (10.70) (1.71) (22.78) (10.15) Gain on sale of undertaking - 63.89 - 63.89 - - Profit/ (Loss) from discontinued operations before taxes - 62.18 (10.70) 62.18 (22.78) (10.15) (d) Tax expense/(income) of discontinued operations - 11.64 (3.47) 11.64 (7.64) (3.86) Profit/ (Loss) after tax from discontinued operations ((c)-(d)) - 50.54 (7.23) 50.54 (15.14) (6.29) The standalone financial results, to the extent of Statement of Profit & Loss and its resulted impact on earnings per share and segment for the quarter and six month ended September 30, 2025 and for the year ended March 31, 2026, have been restated by excluding figures of Meerganj unit which have been included under discontinued operations for comparison purposes. Figures of the balance sheet as at the Six month ended September 30, 2026, exclude figures related to Meerganj unit and are not comparable with the corresponding figures of the previous reporting periods. vii) During the previous year ended March 31, 2026 an action was taken by the Income Tax Department under section 132 of the Income Tax Act, 1961 at the business premises of the Company on October 29, 2025. On receipt of notice under section 158BC of the Act, the Company filed return for the block period from April 01, 2019 to December 27, 2025. Without prejudice to its rights and contentions, in order to mitigate legacy tax uncertainties and avoid/ minimize litigation, the Company offered an ad hoc amount of Rs.4.30 Crores as additional income to tax in the tax return filed for the block period, including an amount of Rs. 0.53 Crores accounted as other income during the quarter ended September 30, 2026. The consequent tax liability of Rs. 2.68 crores has been included in the current tax provisions for the quarter and six months ended September 30, 2026. The Company has not received any orders/demand notices till date. The Management is of the view that there would not be any material adverse impact on the financial position of the Company and hence no material adjustments are required to be made in the financial statements of the Company. viii) The Board of Directors of the Company at its meeting held on November 14, 2026 approved buy back of shares for an amount upto Rs. 50 Crores, with maximum buy back price per share of Rs.200, subject to the approval of shareholders. ix) Sugar being a seasonal industry, the performance of the quarter may not be representative of the annual performance of the Company. x) Figures for the previous corresponding periods have been regrouped, wherever considered necessary.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 86,639.00
Capital work-in-progress 1,478.00
Investment property
Goodwill 0.00
Other intangible assets 0.00
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 2,604.00
Trade receivables, non-current
Loans, non-current 50.00
Other non-current financial assets
1 Others 512.00
Total of other non-current financial assets 512.00
Total non-current financial assets 3,166.00
Deferred tax assets (net)
Other non-current assets
1 Right of Use Assets 277.00
2 Other non-current assets 1,305.00
Total of other non-current assets 1,582.00
Total non-current assets 92,865.00
2 Current assets
Inventories 27,519.00
Current financial asset
Current investments 2,494.00
Trade receivables, current 8,513.00
Cash and cash equivalents 2,604.00
Bank balance other than cash and cash equivalents 7,116.00
Loans, current 0.00
Other current financial assets
Total of other current financial assets 222.00
Total current financial assets 20,949.00
Current tax assets (net)
Other current assets
1 Other current assets 6,305.00
2 Asset held for disposal 49.00
Total of other current assets 6,354.00
Total current assets 54,822.00
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 1,47,687.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 6,639.00
Other equity 1,01,336.00
Total equity attributable to owners of parent 1,07,975.00
Non controlling interest
Total equity 1,07,975.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 7,687.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1 Lease Liabilities 195.00
2 Other Financial Liabilities 150.00
Total of other non-current financial liabilities 345.00
Total non-current financial liabilities 8,032.00
Provisions, non-current 2,109.00
Deferred tax liabilities (net) 4,025.00
Deferred government grants, Non-current
Other non-current liabilities
1 Other non-current liabilities 23.00
Total of other non-current liabilities 23.00
Total non-current liabilities 14,189.00
Current liabilities
Current financial liabilities
Borrowings, current 13,525.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 1,641.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 3,584.00
Total Trade payable 5,225.00
Other current financial liabilities
1 Lease Liabilities 71.00
2 Other current financial liabilities 3,625.00
Total of other current financial liabilities 3,696.00
Total current financial liabilities 22,446.00
Other current liabilities 2,325.00
1 Other current liabilities 2,325.00
Total of other current liabilities 2,325.00
Provisions, current 542.00
Current tax liabilities (Net) 210.00
Deferred government grants, Current
Total current liabilities 25,523.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 39,712.00
Total equity and liabilites 1,47,687.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Sugar 46,867.00 86,098.00
2 Bio Fuels & Spirits 10,442.00 18,520.00
3 Country Liquor 43,791.00 92,699.00
Total Segment Revenue 1,01,100.00 1,97,317.00
Less: Inter segment revenue 1,785.00 4,047.00
Revenue from operations 99,315.00 1,93,270.00
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Sugar 4,758.00 5,231.00
2 Bio Fuels & Spirits 556.00 1,216.00
3 Country Liquor 363.00 708.00
Total Profit before tax 5,677.00 7,155.00
i. Finance cost 787.00 2,343.00
ii. Other Unallocable Expenditure net off Unallocable income 968.00 2,505.00
Profit before tax 3,922.00 2,307.00
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Sugar 86,616.00 86,616.00
2 Bio Fuels & Spirits 32,170.00 32,170.00
3 Country Liquor 11,221.00 11,221.00
Total Segment Asset 1,30,007.00 1,30,007.00
Un-allocable Assets 17,680.00 17,680.00
Net Segment Asset 1,47,687.00 1,47,687.00
4 Segment Liabilities
Segment Liabilities
1 Sugar 6,850.00 6,850.00
2 Bio Fuels & Spirits 1,333.00 1,333.00
3 Country Liquor 4,349.00 4,349.00
Total Segment Liabilities 12,532.00 12,532.00
Un-allocable Liabilities 27,180.00 27,180.00
Net Segment Liabilities 39,712.00 39,712.00
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement benefits (loses) on defined benefit obligation (451.00) (451.00)
Total Amount of items that will not be reclassified to profit and loss (451.00) (451.00)
2 Income tax relating to items that will not be reclassified to profit or loss (114.00) (114.00)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income (337.00) (337.00)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 2,307.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 2,343.00
Adjustments for decrease (increase) in inventories 73,525.00
Adjustments for decrease (increase) in trade receivables, current 29.00
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (176.00)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current (136.00)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (6,245.00)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 685.00
Adjustments for depreciation and amortisation expense 2,582.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current (1,184.00)
Adjustments for other financial liabilities, current 702.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 0.00
Adjustments for dividend income 0.00
Adjustments for interest income 0.00
Adjustments for share-based payments 21.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow (6,389.00)
Other adjustments to reconcile profit (loss) 6,218.00
Other adjustments for non-cash items 97.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 72,072.00
Net cash flows from (used in) operations 74,379.00
Dividends received 0.00
Interest paid 0.00
Interest received (130.00)
Income taxes paid (refund) 1,933.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 72,316.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 1.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 9.00
Purchase of property, plant and equipment 3,583.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 30,500.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 50.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 31.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (9,100.00)
Net cash flows from (used in) investing activities 17,806.00
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 198.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 84,231.00
Payments of lease liabilities 294.00
Dividends paid 990.00
Interest paid 2,255.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (87,968.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 2,154.00
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 2,154.00
Cash and cash equivalents cash flow statement at beginning of period 450.00
Cash and cash equivalents cash flow statement at end of period 2,604.00





Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Dhampur Bio Organics Limited Shudh Edible Products Pvt Ltd Enterprises which have significant influence and also owned or significantly influenced bydirectors/Key Management Personnel or their relatives. Any other transaction Rent paid Approved by Audit Committee 174.00 120.00 120.00
2 Dhampur Bio Organics Limited Intellecta Infotech Pvt Ltd Enterprises which have significant influence and also owned or significantly influenced bydirectors/Key Management Personnel or their relatives. Any other transaction Rent paid Approved by Audit Committee 6.00 3.00 3.00
3 Dhampur Bio Organics Limited Ruchika Mehra Kothari Independent Director Any other transaction Commission to Directors Approved by Audit Committee 12.00 0.00 0.00
4 Dhampur Bio Organics Limited Kishor Shah Independent Director Any other transaction Commission to Directors Approved by Audit Committee 12.00 0.00 0.00
5 Dhampur Bio Organics Limited Bindu Vashist Goel Non Executive Director Any other transaction Commission to Directors Approved by Audit Committee 12.00 0.00 0.00
6 Dhampur Bio Organics Limited Samir Thukral Independent Director Any other transaction Commission to Directors Approved by Audit Committee 12.00 0.00 0.00
7 Dhampur Bio Organics Limited Ashwani Kumar Gupta Independent Director Any other transaction Commission to Directors Approved by Audit Committee 12.00 0.00 0.00
8 Dhampur Bio Organics Limited Vishal Saluja Independent Director Any other transaction Commission to Directors Approved by Audit Committee 12.00 0.00 0.00
9 Dhampur Bio Organics Limited DBION Private Limited Subsidiary Company Loan Approved by Audit Committee 50.00 0.00 50.00
10 Dhampur Bio Organics Limited DBION Private Limited Subsidiary Company Interest received Approved by Audit Committee 1.00 0.00 1.00
11 Dhampur Bio Organics Limited Ashwani Kumar Gupta Independent Director Any other transaction Director Sitting Fee NA 3.00 0.00 0.00
12 Dhampur Bio Organics Limited Bindu Vashist Goel Non Executive Director Any other transaction Director Sitting Fee NA 2.00 0.00 0.00
13 Dhampur Bio Organics Limited Kishor Shah Independent Director Any other transaction Director Sitting Fee NA 3.00 0.00 0.00
14 Dhampur Bio Organics Limited Ruchika Mehra Kothari Independent Director Any other transaction Director Sitting Fee NA 1.00 0.00 0.00
15 Dhampur Bio Organics Limited Samir Thukral Independent Director Any other transaction Director Sitting Fee NA 2.00 0.00 0.00
16 Dhampur Bio Organics Limited Sandeep Kumar Non Executive Director Any other transaction Director Sitting Fee NA 1.00 0.00 0.00
17 Dhampur Bio Organics Limited Vishal Saluja Independent Director Any other transaction Director Sitting Fee NA 2.00 0.00 0.00
18 Dhampur Bio Organics Limited DBOL Employee Welfare Trust Trust formed for benefits of Employee Loan Approved by Audit Committee and approved by shareholders for ESOS 2025 165.00 550.00 715.00
19 Dhampur Bio Organics Limited Sonitron Bio Organics Private limited Wholly Owned Subsidiary Sale of goods or services NA 3,203.00 2,116.00 3.00
20 Dhampur Bio Organics Limited Sonitron Bio Organics Private limited Wholly Owned Subsidiary Purchase of goods or services NA 808.00 0.00 0.00
21 Dhampur Bio Organics Limited Sonitron Bio Organics Private limited Wholly Owned Subsidiary Any other transaction Expenses recovered NA 2.00 0.00 0.00
22 Dhampur Bio Organics Limited Sonitron Bio Organics Private limited Wholly Owned Subsidiary Any other transaction Rent received Approved by Audit Committee 4.00 0.00 0.00
23 Dhampur Bio Organics Limited DBION Private Limited Subsidiary Company Any other transaction Rent received Approved by Audit Committee 0.00 0.00 0.00
24 Dhampur Bio Organics Limited DBION Private Limited Subsidiary Company Investment Approved by Audit Committee 1.00 0.00 1.00
25 Dhampur Bio Organics Limited Sonitron Bio Organics Private limited Wholly Owned Subsidiary Interest received NA 249.00 0.00 0.00
26 Dhampur Bio Organics Limited Sonitron Bio Organics Private limited Wholly Owned Subsidiary Any other transaction Investment Balance NA 0.00 1.00 1.00
27 Dhampur Bio Organics Limited Dhampur International Pte. Ltd. Wholly Owned Subsidiary Any other transaction Investment Balance NA 0.00 5,359.00 5,359.00
28 Dhampur Bio Organics Limited Dhampur International Pte. Ltd. Wholly Owned Subsidiary Any other transaction Deemed Equity Contribution NA 0.00 201.00 201.00
29 Dhampur Bio Organics Limited Gautam Goel Chairman and CEO Dividend paid NA 118.00 0.00 0.00
30 Dhampur Bio Organics Limited Deepa Goel Promoter Dividend paid NA 45.00 0.00 0.00
31 Dhampur Bio Organics Limited Bindu Vashist Goel Non Executive Director Dividend paid NA 1.00 0.00 0.00
32 Dhampur Bio Organics Limited Ruchika Mehra Kothari Independent Director Dividend paid NA 0.00 0.00 0.00
33 Dhampur Bio Organics Limited Sandeep Kumar Non Executive Director Dividend paid NA 0.00 0.00 0.00
34 Dhampur Bio Organics Limited Nalin Kumar Gupta Whole Time Director and CFO Dividend paid NA 0.00 0.00 0.00
35 Dhampur Bio Organics Limited Shudh Edible Products Pvt Ltd Enterprises which have significant influence and also owned or significantly influenced bydirectors/Key Management Personnel or their relatives. Dividend paid NA 170.00 0.00 0.00
36 Dhampur Bio Organics Limited Sonitron Limited Enterprises which have significant influence and also owned or significantly influenced bydirectors/Key Management Personnel or their relatives. Dividend paid NA 172.00 0.00 0.00
37 Dhampur Bio Organics Limited Late Mr. Vijay Kumar Goel Chairman and Executive Director Remuneration Approved by Audit Committee 20.00 11.00 0.00
38 Dhampur Bio Organics Limited Gautam Goel Chairman and CEO Remuneration Approved by Audit Committee 162.00 30.00 26.00
39 Dhampur Bio Organics Limited Sandeep Kumar Non Executive Director Remuneration NA 6.00 5.00 1.00
40 Dhampur Bio Organics Limited Nalin Kumar Gupta Whole Time Director and CFO Remuneration Approved by Audit Committee 56.00 7.00 14.00
41 Dhampur Bio Organics Limited Ashu Rawat Company Secretary Remuneration NA 20.00 3.00 5.00
42 Dhampur Bio Organics Limited Sanjay Gupta Relative of KMP Remuneration NA 4.00 1.00 1.00
43 Dhampur Bio Organics Limited Maayashree Goel Relative of KMP Remuneration Approved by Audit Committee 15.00 1.00 3.00
44 Dhampur Bio Organics Limited Meerashree Goel Relative of KMP Remuneration Approved by Audit Committee 15.00 1.00 3.00
Total value of transaction during the reporting period 5,553.00